Rayan is currently a board member and the CEO of Blue Ocean Health, a Dubai-based healthcare management firm primarily operating in the fields of genetics, fertility, assisted reproduction, fetal-maternal medicine, and tertiary care predominantly in the US, Europe, and the Middle East. He manages entities including Viafet Genomics Laboratory LLC, Jumeirah American Clinic LLC, Jumeriah American IVF and Day Surgery Center FZ (previously First IVF), and Burjeel IVF LLC. He is on the board of IVF Michigan (USA) and appointed as a shareholder director, representing Dr. Michael Fakih, on the board of New Reproductive Care (owner of Fakih IVF companies in the UAE, Qatar, and Oman).
He is also the Deputy CEO of Emirates Hospitals Group, owning and operating a portfolio of over 45 healthcare assets including 2 full-service hospitals (Emirates Hospital Jumeirah and Emirates Specialty Hospital), 3 day surgery centers (EH Motor City, Integra DHCC, and EH Abu Dhabi Day Surgery Center), 15 pharmacies, 5 labs, 2 rehab centers, and over 32 specialized clinics. He is responsible for actively managing Emirates Hospitals Group’s strategic direction, the execution of its turnaround business plan, and the day to day management of the business involving over 3,000 employees including over 450 physicians.
Rayan is a founder and board member of Ithmar Capital Partners, a Category 3C licensed alternative asset management firm based in the DIFC with a focus on private equity, special situations listed equities, and niche real estate strategies. He served as its Managing Partner & CEO from 2015-2019, and was a member of the Investment Committee, and member of the Executive Management Committee, Audit, Risk Compliance and Operations Committee, and Remuneration Committee. He launched ICP Special Situations I LP, a fund with an activist strategy focused on special situations in listed equities across the MENA region.
In 2006, Rayan was a member of the founding team involved in building Algebra Capital, a MENA asset management firm with peak AUM of US$ 1.6 billion, from inception to its gradual sale to Franklin Templeton in 2009-2011. He was retained by Franklin Templeton as a Fund Manager and member of the Investment Committee until he left in 2015. He was in charge of fund management including decisions on asset allocation, investment strategy, and the review and approval of investment opportunities. He was also the Fund Manager on the Alpha Mena Fund, a concentrated and benchmark-agnostic fund with investments in listed equities across the MENA region.
Rayan started his career in 2004 as an analyst at Silverstone Advisors in New York, before moving to Shuaa Capital in the UAE as a junior portfolio manager covering the MENA region in 2005.
He also served as an independent board member of a Kuwaiti-listed civil contracting firm and chaired its audit committee, and is currently a member of the board of trustees of an educational facility for children with special needs in Lebanon. Rayan holds a Bachelor of Commerce degree (with distinction) from the University of Toronto.